According to NCEP goals, if CHD is present, the LDL-C target is:

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

According to NCEP goals, if CHD is present, the LDL-C target is:

Explanation:
In NCEP ATP III guidelines, LDL-C targets are set based on risk category. If coronary heart disease is present (or is a risk-equivalent condition), the goal is to reduce LDL-C to below 100 mg/dL. This level balances the benefit of lowering cholesterol with achievable therapy, given that lower LDL-C reduces recurrent heart events in people with established coronary disease. The other targets aren’t the standard NCEP goal for someone with CHD; 129 and 159 mg/dL are not tight enough for this high-risk group, and 70 mg/dL is a more aggressive target that some guidelines suggest for very high risk, but the classic ATP III recommendation for CHD is <100 mg/dL. Achieving this typically involves statin therapy and lifestyle changes, with therapy intensified as needed to reach the goal.

In NCEP ATP III guidelines, LDL-C targets are set based on risk category. If coronary heart disease is present (or is a risk-equivalent condition), the goal is to reduce LDL-C to below 100 mg/dL. This level balances the benefit of lowering cholesterol with achievable therapy, given that lower LDL-C reduces recurrent heart events in people with established coronary disease. The other targets aren’t the standard NCEP goal for someone with CHD; 129 and 159 mg/dL are not tight enough for this high-risk group, and 70 mg/dL is a more aggressive target that some guidelines suggest for very high risk, but the classic ATP III recommendation for CHD is <100 mg/dL. Achieving this typically involves statin therapy and lifestyle changes, with therapy intensified as needed to reach the goal.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy